Estimate Recalculated Sep 9, 2024 12:23AM EST
W. Mark Watson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, HedgePath Pharmaceuticals, Inc., Vaxart, Inc., TEKLA HEALTHCARE INVESTORS, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund, TEKLA LIFE SCIENCES INVESTORS, and SYKES ENTERPRISES INC.
W. Mark Watson's CIK is 0001612372
2018 was W. Mark Watson's most active year for acquiring shares with 11 total transactions. W. Mark Watson's most active month to acquire stocks was the month of July. 2017 was W. Mark Watson's most active year for disposing of shares, totalling 6 transactions. W. Mark Watson's most active month to dispose stocks was the month of February. 2022 saw W. Mark Watson paying a total of $329,021.60 for 232,011 shares, this is the most they've acquired in one year. In 2020 W. Mark Watson cashed out on 46,000 shares for a total of $145,640.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!